These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8399658)

  • 1. Hematocrit above 30% in continuous ambulatory peritoneal dialysis patients treated with erythropoietin is harmful.
    Junor BJ
    Perit Dial Int; 1993; 13 Suppl 2():S535-7. PubMed ID: 8399658
    [No Abstract]   [Full Text] [Related]  

  • 2. Anemia and erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Korbet SM
    Kidney Int Suppl; 1993 Feb; 40():S111-9. PubMed ID: 8445832
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical effects of recombinant human erythropoietin for the treatment of anemia in end stage renal disease patients on dialysis.
    Uthayanaka Y; Jirajan B; Krairithichai U; Jantavanich N
    Southeast Asian J Trop Med Public Health; 1993 Sep; 24(3):577-82. PubMed ID: 8160072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcutaneous recombinant human erythropoietin in children with renal anemia on continuous ambulatory peritoneal dialysis.
    Aufricht C; Balzar E; Steger H; Lothaller MA; Frenzel K; Kohlhauser C; Kiss H; Khoss AE; Kernova T
    Acta Paediatr; 1993 Nov; 82(11):959-62. PubMed ID: 8111178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin in continuous ambulatory peritoneal dialysis: experience with subcutaneous administration.
    Eisele G; Bailie GR; Clement C; Wong E
    Perit Dial Int; 1992; 12(1):34-6. PubMed ID: 1543777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis efficiency in continuous ambulatory peritoneal dialysis patients treated with erythropoietin.
    Taylor JE; MacTier RA; Henderson IS; Belch JJ; Stewart WK
    Perit Dial Int; 1992; 12(2):221-6. PubMed ID: 1586685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human recombinant erythropoietin in treatment of uremic anemia in children with continual ambulatory peritoneal dialysis].
    Litwin M; Boguszewska-Baczkowska A; Jelonek A
    Pol Tyg Lek; 1994 Feb 7-14; 49(6-7):135-6. PubMed ID: 8090665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statement on the clinical use of recombinant erythropoietin in anemia of end-stage renal disease. Ad Hoc Committee for the National Kidney Foundation.
    Am J Kidney Dis; 1989 Sep; 14(3):163-9. PubMed ID: 2672796
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcutaneous recombinant human erythropoietin in hemodialysis and continuous ambulatory peritoneal dialysis.
    Pais MJ; Gaspar A; Santana A; Bruges M; Simões J
    Perit Dial Int; 1993; 13 Suppl 2():S541-3. PubMed ID: 8399660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National cooperative rHu erythropoietin study in patients with chronic renal failure: a phase IV multicenter study. Report of National Cooperative rHu Erythropoietin Study Group.
    Nissenson AR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):24-33. PubMed ID: 1928075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of erythropoietin in the reversal of anemia of renal failure with continuous ambulatory peritoneal dialysis.
    Chandra M; McVicar M; Clemons G; Mossey RT; Wilkes BM
    Nephron; 1987; 46(3):312-5. PubMed ID: 3627325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of low-dose subcutaneous recombinant human erythropoietin in end-stage renal disease: experience with children receiving continuous cycling peritoneal dialysis.
    Ongkingco JR; Ruley EJ; Turner ME
    Am J Kidney Dis; 1991 Oct; 18(4):446-50. PubMed ID: 1928063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin for chronic ambulatory peritoneal dialysis patients: once a week can be enough.
    Hood VL; Ingraham A
    J Am Soc Nephrol; 1992 Apr; 2(10):1545-6. PubMed ID: 1600126
    [No Abstract]   [Full Text] [Related]  

  • 14. Hematocrit influence on peritoneal dialysis effectiveness during recombinant human erythropoietin treatment in patients with chronic renal failure.
    Ksiazek A; Baranowska-Daca E
    Perit Dial Int; 1993; 13 Suppl 2():S550-2. PubMed ID: 8399662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of recombinant erythropoietin on the early hematocrit rise after CAPD initiation.
    Golper TA
    Perit Dial Int; 1992; 12(1):37-9. PubMed ID: 1543778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythropoietin therapy in peritoneal dialysis patients.
    Morris AT; Ronco C
    Perit Dial Int; 2000; 20 Suppl 2():S178-82. PubMed ID: 10911666
    [No Abstract]   [Full Text] [Related]  

  • 17. Low-dose erythropoietin is effective and safe in children on continuous ambulatory peritoneal dialysis.
    Yalçinkaya F; Tümer N; Cakar N; Ozkaya N
    Pediatr Nephrol; 1997 Jun; 11(3):350-2. PubMed ID: 9203190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dialysis dose, membrane type, and anemia control.
    Young EW
    Am J Kidney Dis; 1998 Dec; 32(6 Suppl 4):S157-60. PubMed ID: 9892384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of hemodialysis and peritoneal dialysis in the management of anemia related to chronic renal disease.
    Korbet SM
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):9-15. PubMed ID: 2648520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron dextran treatment in peritoneal dialysis patients on erythropoietin.
    Suh H; Wadhwa NK
    Adv Perit Dial; 1992; 8():464-6. PubMed ID: 1361849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.